Schwartz Z, Somers A, Mellonig J T, Carnes D L, Dean D D, Cochran D L, Boyan B D
Department of Periodontics, Hebrew University Faculty of Dental Medicine, Jerusalem, Israel.
J Periodontol. 1998 Apr;69(4):470-8. doi: 10.1902/jop.1998.69.4.470.
Demineralized freeze-dried bone allografts (DFDBA) have been used extensively in periodontal therapy. DFDBA is used because it contains bone morphogenetic protein (BMP), which induces new bone formation during the healing process. Most commercial bone banks do not verify the presence or activity of BMP in DFDBA nor the ability of DFDBA to induce new bone. Recently, we showed that different bone bank preparations of DFDBA, even from the same bank, varied considerably in their ability to induce new bone, suggesting inherent differences in the quality of the material. Therefore, we examined whether donor age or gender contributed to the variability seen with these preparations. Twenty-seven batches of DFDBA from different donors were donated by one bone bank which had been shown previously to supply DFDBA that was consistently able to induce new bone formation. Each batch was implanted bilaterally in the thigh muscle of nude mice. After 56 days, the implants were excised and examined by light microscopy and histomorphometry. Seventy percent of the preparations tested induced new bone formation. Most of these preparations produced ossicles containing cortical bone surrounding bone marrow-like tissue. The ability to induce bone appears to be age-dependent, with DFDBA from older donors being less likely to have strong bone-inducing activity. By contrast, no difference in ability to induce new bone was noticed between male or female donors. The results of this study confirm that commercial preparations of DFDBA differ in their ability to induce new bone formation. In fact, some of the batches had no activity at all. The ability of DFDBA to induce new bone formation is suggested to be age-dependent, but not gender-dependent by our study. These results indicate that commercial bone banks need to verify the ability of DFDBA to induce new bone formation and should reconsider the advisability of using bone from older donors.
脱矿冻干骨同种异体移植(DFDBA)已广泛应用于牙周治疗。使用DFDBA是因为它含有骨形态发生蛋白(BMP),该蛋白在愈合过程中可诱导新骨形成。大多数商业骨库并未验证DFDBA中BMP的存在或活性,也未验证DFDBA诱导新骨的能力。最近,我们发现不同骨库制备的DFDBA,即使来自同一骨库,其诱导新骨的能力也有很大差异,这表明材料质量存在内在差异。因此,我们研究了供体年龄或性别是否导致了这些制剂中观察到的变异性。一家骨库捐赠了来自不同供体的27批DFDBA,该骨库先前已证明所提供的DFDBA始终能够诱导新骨形成。每批均双侧植入裸鼠大腿肌肉。56天后,取出植入物并通过光学显微镜和组织形态计量学进行检查。70%的测试制剂诱导了新骨形成。这些制剂中的大多数产生了含有围绕骨髓样组织的皮质骨的小骨。诱导骨的能力似乎与年龄有关,来自老年供体的DFDBA诱导骨活性强的可能性较小。相比之下,未观察到男性或女性供体在诱导新骨能力上的差异。本研究结果证实,DFDBA的商业制剂在诱导新骨形成的能力方面存在差异。事实上,有些批次根本没有活性。我们的研究表明,DFDBA诱导新骨形成的能力与年龄有关,但与性别无关。这些结果表明,商业骨库需要验证DFDBA诱导新骨形成的能力,并应重新考虑使用老年供体骨的可取性。